Curcumin and cancer: barriers to obtaining a health claim.
暂无分享,去创建一个
Ifeanyi D. Nwachukwu | P. Jones | Peter J H Jones | Jessay G Devassy | Ifeanyi D Nwachukwu | J. Devassy | P. Jones
[1] S. Joyal,et al. A Pilot Cross-Over Study to Evaluate Human Oral Bioavailability of BCM-95®CG (Biocurcumax™), A Novel Bioenhanced Preparation of Curcumin , 2008, Indian journal of pharmaceutical sciences.
[2] W. Wheaton,et al. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity , 2010, Proceedings of the National Academy of Sciences.
[3] R. Planalp,et al. Curcumin: From ancient medicine to current clinical trials , 2008, Cellular and Molecular Life Sciences.
[4] B. Stewart,et al. World cancer report 2014. , 2014 .
[5] G. Dontu,et al. Targeting breast stem cells with the cancer preventive compounds curcumin and piperine , 2010, Breast Cancer Research and Treatment.
[6] M. Pirmohamed,et al. Phase I Clinical Trial of Oral Curcumin , 2004, Clinical Cancer Research.
[7] B. Aggarwal,et al. Anticancer potential of curcumin: preclinical and clinical studies. , 2003, Anticancer research.
[8] A. Shehzad,et al. Molecular mechanisms of curcumin action: Signal transduction , 2013, BioFactors.
[9] Havva Şahin Kavaklı,et al. Sıçanlarda spinal kord yaralanmsında curcuminin antioksidan etkileri , 2011 .
[10] Makoto Takahashi,et al. Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin. , 2009, Journal of agricultural and food chemistry.
[11] B. Aggarwal,et al. Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. , 2007, Carcinogenesis.
[12] F. Ruscetti,et al. Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: increased binding of cyclin A negatively regulates E2F transactivation activity. , 1997, Cancer research.
[13] E. Larsson,et al. Antioxidants Accelerate Lung Cancer Progression in Mice , 2014, Science Translational Medicine.
[14] S. Wexner,et al. Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[15] D. Albanes,et al. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.
[16] B. Aggarwal,et al. Multitargeting by turmeric, the golden spice: From kitchen to clinic. , 2013, Molecular nutrition & food research.
[17] R. Ramakrishna,et al. Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: A randomized, double‐blind placebo‐controlled cross‐over 4g study and an open‐label 8g extension study , 2012, American journal of hematology.
[18] D. Heber,et al. Role of tomatoes, tomato products and lycopene in cancer prevention. , 2001, Advances in experimental medicine and biology.
[19] R. Benya,et al. Phase IIa Clinical Trial of Curcumin for the Prevention of Colorectal Neoplasia , 2011, Cancer Prevention Research.
[20] B. Stefańska. Curcumin ameliorates hepatic fibrosis in type 2 diabetes mellitus – insights into its mechanisms of action , 2012, British journal of pharmacology.
[21] Z. Chen,et al. New Perspectives of Curcumin in Cancer Prevention , 2013, Cancer Prevention Research.
[22] Daniel Normolle,et al. Dose escalation of a curcuminoid formulation , 2006, BMC complementary and alternative medicine.
[23] Hailong Yu,et al. Improving the oral bioavailability of curcumin using novel organogel-based nanoemulsions. , 2012, Journal of agricultural and food chemistry.
[24] B. Aggarwal,et al. Curcumin and cancer: an "old-age" disease with an "age-old" solution. , 2008, Cancer letters.
[25] B. Patel,et al. Colorectal Cancer: Chemopreventive Role of Curcumin and Resveratrol , 2010, Nutrition and cancer.
[26] T. Tsai,et al. Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[27] Zhenyu Ji,et al. Targeting DNA Damage and Repair by Curcumin , 2010, Breast cancer : basic and clinical research.
[28] B. Aggarwal,et al. Curcumin and Cancer Cells: How Many Ways Can Curry Kill Tumor Cells Selectively? , 2009, The AAPS Journal.
[29] B. Patel,et al. Synergistic Role of Curcumin With Current Therapeutics in Colorectal Cancer: Minireview , 2009, Nutrition and cancer.
[30] M. Kanai. Therapeutic applications of curcumin for patients with pancreatic cancer. , 2014, World journal of gastroenterology.
[31] C. Aebi,et al. Antibacterial and Antiinflammatory Kinetics of Curcumin as a Potential Antimucositis Agent in Cancer Patients , 2012, Nutrition and cancer.
[32] A. Wolk,et al. Vitamin C and survival among women with breast cancer: a meta-analysis. , 2014, European journal of cancer.
[33] Liandong Hu,et al. Preparation and enhancement of oral bioavailability of curcumin using microemulsions vehicle. , 2012, Journal of agricultural and food chemistry.
[34] A. Ingle,et al. Inhibitory effects of curcumin-free aqueous turmeric extract on benzo[a]pyrene-induced forestomach papillomas in mice. , 1997, Cancer letters.
[35] S. Moncada,et al. Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.
[36] Zhenyu Ji. Article Commentary: Targeting DNA Damage and Repair by Curcumin , 2010 .
[37] J. Mellon,et al. Chemoprevention of prostate cancer by diet-derived antioxidant agents and hormonal manipulation (Review). , 2003, International journal of oncology.
[38] A. Ingle,et al. Chemopreventive efficacy of curcumin-free aqueous turmeric extract in 7,12-dimethylbenz[a]anthracene-induced rat mammary tumorigenesis. , 1998, Cancer letters.
[39] A. Munshi,et al. Antioxidant potential of curcumin against oxidative insult induced by pentylenetetrazol in epileptic rats. , 2010, Methods and findings in experimental and clinical pharmacology.
[40] S. Mukherjee,et al. Curcumin prevents DNA damage and enhances the repair potential in a chronically arsenic-exposed human population in West Bengal, India , 2011, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[41] J. Pedraza-Chaverri,et al. Renoprotective effect of the antioxidant curcumin: Recent findings , 2013, Redox biology.
[42] Jeffrey R. Wang,et al. The molecular mechanism of action of aspirin, curcumin and sulforaphane combinations in the chemoprevention of pancreatic cancer , 2013, Oncology reports.
[43] Zhiwei Wang,et al. Lesson learned from nature for the development of novel anti-cancer agents: implication of isoflavone, curcumin, and their synthetic analogs. , 2010, Current pharmaceutical design.
[44] M. Majeed,et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. , 1998, Planta medica.
[45] Jun Li,et al. Antioxidant and antiinflammatory activities of curcumin on diabetes mellitus and its complications. , 2013, Current pharmaceutical design.
[46] K. Prasad,et al. High doses of multiple antioxidant vitamins: essential ingredients in improving the efficacy of standard cancer therapy. , 1999, Journal of the American College of Nutrition.
[47] V. Ghalaut,et al. Effect of imatinib therapy with and without turmeric powder on nitric oxide levels in chronic myeloid leukemia , 2012, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
[48] Takuji Tanaka,et al. Chemopreventive Effect of Curcumin on N‐Nitrosomethylbenzylamine‐induced Esophageal Carcinogenesis in Rats , 2000, Japanese journal of cancer research : Gann.
[49] P. Jones,et al. Generic and product-specific health claim processes for functional foods across global jurisdictions. , 2008, The Journal of nutrition.
[50] Jaetae Lee,et al. Curcumin in various cancers , 2013, BioFactors.
[51] R. D'Agostino,et al. Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator. , 2009, Blood.
[52] Y. Oshima,et al. Antihepatotoxic Principles of Curcuma longa Rhizomes1 , 1983, Planta medica.
[53] N. Vermeulen,et al. Inhibition of human recombinant cytochrome P450s by curcumin and curcumin decomposition products. , 2007, Toxicology.
[54] G. Appendino,et al. Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. , 2011, Journal of natural products.
[55] H. Lou,et al. Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin. , 2006, Journal of pharmaceutical and biomedical analysis.
[56] P. Suryanarayana,et al. Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats. , 2005, Investigative ophthalmology & visual science.
[57] C. Koca,et al. Antioxidant effects of curcumin in spinal cord injury in rats. , 2011, Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES.
[58] Razelle Kurzrock,et al. Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer , 2008, Clinical Cancer Research.
[59] S. Horie,et al. Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate‐specific antigen , 2010, The Prostate.
[60] Namitha,et al. A pilot study of the antioxidant effect of curcumin in tropical pancreatitis. , 2005, The Indian journal of medical research.
[61] Jacob M. Wilson,et al. Comparative absorption of curcumin formulations , 2014, Nutrition Journal.
[62] M. L’Abbé,et al. Health claims on foods in Canada. , 2008, The Journal of nutrition.
[63] T. Shanafelt,et al. Curcumin Inhibits Prosurvival Pathways in Chronic Lymphocytic Leukemia B Cells and May Overcome Their Stromal Protection in Combination with EGCG , 2009, Clinical Cancer Research.
[64] R. Basha,et al. The impact of curcumin on breast cancer. , 2012, Integrative biology : quantitative biosciences from nano to macro.
[65] B. Aggarwal,et al. Turmeric (Curcuma longa) inhibits inflammatory nuclear factor (NF)-κB and NF-κB-regulated gene products and induces death receptors leading to suppressed proliferation, induced chemosensitization, and suppressed osteoclastogenesis. , 2012, Molecular nutrition & food research.
[66] Jianguo Lin,et al. Curcumin diminishes the impacts of hyperglycemia on the activation of hepatic stellate cells by suppressing membrane translocation and gene expression of glucose transporter-2 , 2011, Molecular and Cellular Endocrinology.
[67] Y. Makino,et al. Novel curcumin oral delivery systems. , 2013, Anticancer research.
[68] S. Nakornchai,et al. Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives. , 2007, Biological & pharmaceutical bulletin.
[69] Robert A Newman,et al. Bioavailability of curcumin: problems and promises. , 2007, Molecular pharmaceutics.
[70] M. Mouret-Reynier,et al. Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer , 2010, Cancer biology & therapy.
[71] G. Bar-Sela,et al. Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer , 2010, Nutrition and cancer.
[72] M. Fujita,et al. Innovative preparation of curcumin for improved oral bioavailability. , 2011, Biological & pharmaceutical bulletin.
[73] Chi-Hsien Liu,et al. Antimicrobial activity of curcumin-loaded myristic acid microemulsions against Staphylococcus epidermidis. , 2012, Chemical & pharmaceutical bulletin.
[74] S. Mukherjee,et al. Curcumin-induced apoptosis in human leukemia cell HL-60 is associated with inhibition of telomerase activity , 2007, Molecular and Cellular Biochemistry.
[75] D. Tuveson,et al. The promise and perils of antioxidants for cancer patients. , 2014, The New England journal of medicine.
[76] J. Pedraza-Chaverri,et al. Mitochondria as a Target in the Therapeutic Properties of Curcumin , 2014, Archiv der Pharmazie.
[77] Serge Eifes,et al. Chemopreventive potential of curcumin in prostate cancer , 2010, Genes & Nutrition.
[78] B. Aggarwal,et al. Curcumin, a component of turmeric: From farm to pharmacy , 2013, BioFactors.
[79] T. Salo,et al. Nutraceuticals as new treatment approaches for oral cancer--I: Curcumin. , 2013, Oral oncology.
[80] S. Sagar. Antioxidants during anticancer therapy , 2004, Focus on Alternative and Complementary Therapies.
[81] Ricky A. Sharma,et al. Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[82] Chuanbing Shi,et al. Upregulation of p53 Expression in Patients with Colorectal Cancer by Administration of Curcumin , 2011, Cancer investigation.
[83] K. Prasad,et al. Effect of individual and multiple antioxidant vitamins on growth and morphology of human nontumorigenic and tumorigenic parotid acinar cells in culture. , 1996, Nutrition and cancer.
[84] A. Shehzad,et al. Curcumin: Multiple molecular targets mediate multiple pharmacological actions: A review , 2010, Drugs of the Future.
[85] Mi-Kyung Lee,et al. Effect of curcumin supplementation on blood glucose, plasma insulin, and glucose homeostasis related enzyme activities in diabetic db/db mice. , 2008, Molecular nutrition & food research.
[86] Yan-yan Xing,et al. Curcumin Protects Microglia and Primary Rat Cortical Neurons against HIV-1 gp120-Mediated Inflammation and Apoptosis , 2013, PloS one.
[87] M. Vinayak,et al. Anti-carcinogenic action of curcumin by activation of antioxidant defence system and inhibition of NF-κB signalling in lymphoma-bearing mice. , 2012, Bioscience reports.
[88] R. Means. Ironing out complementary medicine. , 2009, Blood.
[89] V. Menon,et al. Protective effect of curcumin on gamma-radiation induced DNA damage and lipid peroxidation in cultured human lymphocytes. , 2006, Mutation research.
[90] Luciana Facco Dalmolin,et al. Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in rats. , 2013, Colloids and surfaces. B, Biointerfaces.
[91] M. Chan,et al. Long-term use of an antiinflammatory, curcumin, suppressed type 1 immunity and exacerbated visceral leishmaniasis in a chronic experimental model , 2008, Laboratory Investigation.
[92] H. Kishida,et al. Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice. , 2005, Journal of agricultural and food chemistry.
[93] C. Heckler,et al. Curcumin for Radiation Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Thirty Breast Cancer Patients , 2013, Radiation research.
[94] R. Salganik. The Benefits and Hazards of Antioxidants: Controlling Apoptosis and Other Protective Mechanisms in Cancer Patients and the Human Population , 2001, Journal of the American College of Nutrition.
[95] T. Osawa,et al. Involvement of the beta-diketone moiety in the antioxidative mechanism of tetrahydrocurcumin. , 1996, Biochemical pharmacology.
[96] H. Ammon,et al. Pharmacology of Curcuma longa , 1991, Planta medica.
[97] T. Kajiwara. Breast-Conserving therapy: Experience of the breast cancer research group of Tokyo women’s medical college , 1997, Breast cancer.
[98] G. Nair,et al. Antimicrobial Activity of Curcumin against Helicobacter pylori Isolates from India and during Infections in Mice , 2009, Antimicrobial Agents and Chemotherapy.
[99] Donald J L Jones,et al. Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. , 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[100] Jun Cao,et al. Mitochondrial and nuclear DNA damage induced by curcumin in human hepatoma G2 cells. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[101] A. Nagler,et al. Ascorbic acid inhibits apoptosis induced by X irradiation in HL60 myeloid leukemia cells. , 1999, Radiation research.